Crosstalk between Depression, Anxiety, and Dementia: Comorbidity in Behavioral Neurology and Neuropsychiatry

This Special Issue highlights the most recent research on depression, anxiety and dementia, with attention to comorbidity in a range of diseases. The symptoms of depression, anxiety and dementia are the most common comorbid manifestations present in patients suffering from neurodegenerative and psyc...

Full description

Saved in:
Bibliographic Details
Sonstige:
Year of Publication:2022
Language:English
Physical Description:1 electronic resource (266 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993545286104498
ctrlnum (CKB)5690000000011939
(oapen)https://directory.doabooks.org/handle/20.500.12854/87528
(EXLCZ)995690000000011939
collection bib_alma
record_format marc
spelling Tanaka, Masaru edt
Crosstalk between Depression, Anxiety, and Dementia: Comorbidity in Behavioral Neurology and Neuropsychiatry
Crosstalk between Depression, Anxiety, and Dementia
Basel MDPI - Multidisciplinary Digital Publishing Institute 2022
1 electronic resource (266 p.)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
This Special Issue highlights the most recent research on depression, anxiety and dementia, with attention to comorbidity in a range of diseases. The symptoms of depression, anxiety and dementia are the most common comorbid manifestations present in patients suffering from neurodegenerative and psychiatric diseases. Together, these illnesses constitute an extremely complex and challenging research field due to their inherent multifactorial causative factors, heterogeneous pathogenesis, and mental and behavioral manifestations. This Special Issue covers laboratory, clinical and statistical studies on the crosstalk between depression, anxiety, dementia, Alzheimer’s disease, multiple sclerosis, schizophrenia, diabetes mellitus, Down’s syndrome, and/or compulsive disorders. It contains contributions from 71 authors, has been reviewed by 25 referees, and edited by three academic editors and one managing editor.
English
Medicine bicssc
Clinical & internal medicine bicssc
dementia
behavioral and psychological symptoms of dementia
systematic review
meta-analysis
animal-assisted intervention
pet-robot intervention
G protein-coupled receptors
GPR120
FFAR4
schizophrenia
polyunsaturated fatty acids
long-chain fatty acids
omega-3
nutritional psychiatry
Alzheimer’s disease
psychiatric disease
depression
anxiety
Down’s syndrome
inositol
nutraceutical
insulin signaling
antioxidant
aging
psilocybin
clinical trials
oxidative stress
redox
multiple sclerosis
biomarker
neurodegenerative disease
personalized medicine
major depressive disorder
longitudinal study
LC-MS/MS
plasma protein biomarker
drug response monitoring
multiple reaction monitoring
diabetes mellitus
type 2
dyslipidemias
hypertension
post-stroke depression
disability level
mortality
late-life depression
neuroimaging
resting-state functional magnetic resonance imaging
default mode network
executive control network
salience network
healthy life expectancy (HALE)
morbidity/mortality paradox
cognition
systolic blood pressure
cerebral blood flow
arterial properties
angiogenesis
gender medicine
neurodegenerative disorders
kisspeptin
locomotion
Kiss1 receptor
HPA axis
HPG axis
nucleus accumbens
stroke
lipid
diabetes
3-0365-4001-6
3-0365-4002-4
Tanaka, Masaru oth
language English
format eBook
author2 Tanaka, Masaru
author_facet Tanaka, Masaru
author2_variant m t mt
author2_role Sonstige
title Crosstalk between Depression, Anxiety, and Dementia: Comorbidity in Behavioral Neurology and Neuropsychiatry
spellingShingle Crosstalk between Depression, Anxiety, and Dementia: Comorbidity in Behavioral Neurology and Neuropsychiatry
title_full Crosstalk between Depression, Anxiety, and Dementia: Comorbidity in Behavioral Neurology and Neuropsychiatry
title_fullStr Crosstalk between Depression, Anxiety, and Dementia: Comorbidity in Behavioral Neurology and Neuropsychiatry
title_full_unstemmed Crosstalk between Depression, Anxiety, and Dementia: Comorbidity in Behavioral Neurology and Neuropsychiatry
title_auth Crosstalk between Depression, Anxiety, and Dementia: Comorbidity in Behavioral Neurology and Neuropsychiatry
title_alt Crosstalk between Depression, Anxiety, and Dementia
title_new Crosstalk between Depression, Anxiety, and Dementia: Comorbidity in Behavioral Neurology and Neuropsychiatry
title_sort crosstalk between depression, anxiety, and dementia: comorbidity in behavioral neurology and neuropsychiatry
publisher MDPI - Multidisciplinary Digital Publishing Institute
publishDate 2022
physical 1 electronic resource (266 p.)
isbn 3-0365-4001-6
3-0365-4002-4
illustrated Not Illustrated
work_keys_str_mv AT tanakamasaru crosstalkbetweendepressionanxietyanddementiacomorbidityinbehavioralneurologyandneuropsychiatry
AT tanakamasaru crosstalkbetweendepressionanxietyanddementia
status_str n
ids_txt_mv (CKB)5690000000011939
(oapen)https://directory.doabooks.org/handle/20.500.12854/87528
(EXLCZ)995690000000011939
carrierType_str_mv cr
is_hierarchy_title Crosstalk between Depression, Anxiety, and Dementia: Comorbidity in Behavioral Neurology and Neuropsychiatry
author2_original_writing_str_mv noLinkedField
_version_ 1796649052860841984
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04324nam-a2201141z--4500</leader><controlfield tag="001">993545286104498</controlfield><controlfield tag="005">20231214133038.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202207s2022 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5690000000011939</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/87528</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995690000000011939</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Tanaka, Masaru</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Crosstalk between Depression, Anxiety, and Dementia: Comorbidity in Behavioral Neurology and Neuropsychiatry</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Crosstalk between Depression, Anxiety, and Dementia</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (266 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This Special Issue highlights the most recent research on depression, anxiety and dementia, with attention to comorbidity in a range of diseases. The symptoms of depression, anxiety and dementia are the most common comorbid manifestations present in patients suffering from neurodegenerative and psychiatric diseases. Together, these illnesses constitute an extremely complex and challenging research field due to their inherent multifactorial causative factors, heterogeneous pathogenesis, and mental and behavioral manifestations. This Special Issue covers laboratory, clinical and statistical studies on the crosstalk between depression, anxiety, dementia, Alzheimer’s disease, multiple sclerosis, schizophrenia, diabetes mellitus, Down’s syndrome, and/or compulsive disorders. It contains contributions from 71 authors, has been reviewed by 25 referees, and edited by three academic editors and one managing editor.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Clinical &amp; internal medicine</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dementia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">behavioral and psychological symptoms of dementia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">systematic review</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">meta-analysis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">animal-assisted intervention</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pet-robot intervention</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">G protein-coupled receptors</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">GPR120</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">FFAR4</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">schizophrenia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">polyunsaturated fatty acids</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">long-chain fatty acids</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">omega-3</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nutritional psychiatry</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Alzheimer’s disease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">psychiatric disease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">depression</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">anxiety</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Down’s syndrome</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">inositol</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nutraceutical</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">insulin signaling</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antioxidant</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">aging</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">psilocybin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">clinical trials</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">oxidative stress</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">redox</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">multiple sclerosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">biomarker</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">neurodegenerative disease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">personalized medicine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">major depressive disorder</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">longitudinal study</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">LC-MS/MS</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">plasma protein biomarker</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">drug response monitoring</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">multiple reaction monitoring</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">diabetes mellitus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">type 2</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dyslipidemias</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hypertension</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">post-stroke depression</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">disability level</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mortality</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">late-life depression</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">neuroimaging</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">resting-state functional magnetic resonance imaging</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">default mode network</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">executive control network</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">salience network</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">healthy life expectancy (HALE)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">morbidity/mortality paradox</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cognition</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">systolic blood pressure</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cerebral blood flow</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">arterial properties</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">angiogenesis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">gender medicine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">neurodegenerative disorders</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">kisspeptin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">locomotion</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Kiss1 receptor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">HPA axis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">HPG axis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nucleus accumbens</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">stroke</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lipid</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">diabetes</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-4001-6</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-4002-4</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tanaka, Masaru</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:40:31 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-07-14 08:50:39 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5337848390004498&amp;Force_direct=true</subfield><subfield code="Z">5337848390004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337848390004498</subfield></datafield></record></collection>